No correlation was found between NA BA2 titers following the fourth dose and age, sex, comorbidities (diabetes mellitus, hypertension, dyslipidemia, and impaired renal function), or subtypes of immunosuppression treatment (MMF, mTOR, or prednisone). Here, CD9 is linked to hypertensive disorder.